TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06678672

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Contingency Management (CM)
Description: The participants will receive and be trained to use a CO monitor and iCO app to upload videos to verify smoking abstinence at a minimum of once per day, 5 times per week, over 5 weeks. Financial incentives will be provided at weekly visits contingent on tobacco abstinence verified through remote CO monitoring. They will receive clinician feedback at the time of each CO reading, following the established VA CM protocol developed in the earlier phase of the project. Each CO reading during the weeks 2-5 will also be accompanied with a brief (5-minute) telephone or video feedback CM counseling session from the study clinician.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as Usual (TAU)
Description: Participants assigned to TAU will receive usual care at San Francisco VA Health Care System (SFVAHCS), i.e., referral to Tobacco Cessation Clinic and the VA Telequit Quitline. The SFVAHCS Tobacco Cessation Clinic is a consult service that calls patients proactively 3 times to offer 1:1 behavioral counseling for smoking cessation. VA Telequit is a national toll-free number available to Veterans that allows them to speak with a smoking cessation counselor for up to 5 sessions per NCI Quitline guidelines. The smoker initiates the first call, and subsequent calls will be proactively made by Quitline staff.
Study: NCT06679556

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Strength A Sublingual Minoxidil
Description: One single dose of Strength A sublingual minoxidil

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Strength B Sublingual Minoxidil
Description: One single dose of Strength B sublingual minoxidil
Study: NCT06679751

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ID-TOUCH
Description: ID TOUCH is a multi-pronged intervention to increase HIV testing and PrEP linkage that includes jail-based HIV care process improvements with post-incarceration outreach and linkage to community services.
Study: NCT06677736

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: conventional scaling and debridement
Description: conventional scaling and debridement

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: conventional scaling and debridement
Description: conventional scaling and debridement

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Diode laser as adjunctive to conventional scaling and debridement
Description: Diode laser as adjunctive to conventional scaling and debridement

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Diode laser as adjunctive to conventional scaling and debridement
Description: Diode laser as adjunctive to conventional scaling and debridement
Study: NCT06679673

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-1701
Description: SHR-1701

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BP102
Description: BP102

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR2554
Description: SHR2554
Study: NCT06677944

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Preoperative PBI
Description: Preoperative PBI: 21 Gy \* 1 fraction Preoperative PBI is administered within 6 weeks of the patient's initial registration, and surgery is scheduled within 8 to 12 weeks after PBI.
Study: NCT05039489

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antipsychotic drugs
Description: Stable antipsychotic medication 4 weeks before and during the treatment. Chlorpromazine (CPZ) equivalent dosages were calculated for second- and first-generation antipsychotic drugs

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Antipsychotic drugs
Description: Stable antipsychotic medication 4 weeks before and during the treatment. Chlorpromazine (CPZ) equivalent dosages were calculated for second- and first-generation antipsychotic drugs

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Antipsychotic drugs
Description: Stable antipsychotic medication 4 weeks before and during the treatment. Chlorpromazine (CPZ) equivalent dosages were calculated for second- and first-generation antipsychotic drugs

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antipsychotic drugs
Description: Stable antipsychotic medication 4 weeks before and during the treatment. Chlorpromazine (CPZ) equivalent dosages were calculated for second- and first-generation antipsychotic drugs

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antipsychotic drugs
Description: Stable antipsychotic medication 4 weeks before and during the treatment. Chlorpromazine (CPZ) equivalent dosages were calculated for second- and first-generation antipsychotic drugs

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: cTBS（the left temporoparietal cortex as the stimulation target）
Description: Participants received 3 daily sessions of cTBS treatment. One session of cTBS was 40 seconds in duration and consisted of 3-pulse bursts at 50 Hz repeated every 200 milliseconds (5 Hz) until a total of 600 pulses was reached. To achieve cumulative aftereffects, this protocol was repeated 3 times and (1800 pulses in total) separated by two 15 minute breaks

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: cTBS （the left cerebellum Crus II as the stimulation target）
Description: Participants received 3 daily sessions of cTBS treatment. One session of cTBS was 40 seconds in duration and consisted of 3-pulse bursts at 50 Hz repeated every 200 milliseconds (5 Hz) until a total of 600 pulses was reached. To achieve cumulative aftereffects, this protocol was repeated 3 times and (1800 pulses in total) separated by two 15 minute breaks
Study: NCT05484778

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Dual tasking paradigm
Description: The dual task methodology is a testing model that requires one person to perform two tasks at the same time. The dual task is divided into two as motor-motor or motor-cognitive. Dual tasks provide an opportunity to examine the attention demands of both tasks and allow possible interference to be observed. The idea behind this design is that central processing capacity has a limit and must be distributed among concurrent tasks.

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Dual tasking paradigm
Description: The dual task methodology is a testing model that requires one person to perform two tasks at the same time. The dual task is divided into two as motor-motor or motor-cognitive. Dual tasks provide an opportunity to examine the attention demands of both tasks and allow possible interference to be observed. The idea behind this design is that central processing capacity has a limit and must be distributed among concurrent tasks.
Study: NCT05034133

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: Durvalumab (IV 1000mg on day 1) with chemotherapy (Etoposide and Cisplatin) for 6 cycles
Study: NCT06624371

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atovaquone
Description: Atovaquone oral suspension (750 mg/5mL) will be administered with meals on an outpatient basis.~Patients 13 years and older will receive atovaquone 750 mg PO BID, the standard pediatric dosing for Pneumocystis Jirovecii Pneumonia (PJP) prevention and treatment.~For those aged 2-12 years, atovaquone will be dosed at 30mg/kg once daily. The maximum dose for children under 12 will be 1500 mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atovaquone
Description: Atovaquone oral suspension (750 mg/5mL) will be administered with meals on an outpatient basis.~Patients 13 years and older will receive atovaquone 750 mg PO BID, the standard pediatric dosing for Pneumocystis Jirovecii Pneumonia (PJP) prevention and treatment.~For those aged 2-12 years, atovaquone will be dosed at 30mg/kg once daily. The maximum dose for children under 12 will be 1500 mg.

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation Therapy
Description: 54-60 Gy in 1.8 Gy daily fractions of MRI-guided proton radiotherapy using intensity-modulated pencil-beam scanning technology to match the target will be used.
Study: NCT05917210

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard TB-EC
Description: Standard TB-EC by healthcare workers

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Peer navigation strategy for TB-EC
Description: multi-component, peer-navigation strategy for TB-EC
Study: NCT05039489

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: cTBS （the left cerebellum Crus II as the stimulation target）
Description: Participants received 3 daily sessions of cTBS treatment. One session of cTBS was 40 seconds in duration and consisted of 3-pulse bursts at 50 Hz repeated every 200 milliseconds (5 Hz) until a total of 600 pulses was reached. To achieve cumulative aftereffects, this protocol was repeated 3 times and (1800 pulses in total) separated by two 15 minute breaks
Study: NCT06624371

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation Therapy
Description: 54-60 Gy in 1.8 Gy daily fractions of MRI-guided proton radiotherapy using intensity-modulated pencil-beam scanning technology to match the target will be used.
Study: NCT05263596

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: dual x-ray absorptiometry, body impedance analysis, muscle strength measurements, ultrasound
Description: Results from the routine geriatric assessment:~* Mini Mental State Exam (MMSE)~* Clock-drawing test (CDT)~* Geriatric depression scale (GDS)~* Functional independence measure (FIM) at admission~* Timed up and go Test (TUG)~* Gait speed~* Hand grip strength (HGS)~* Nutritional risk screening (NRS)~Additional measurements:~* Chair-stand-test~* Clinical frailty scale (CFS)~* Calf circumference and mid-arm circumference~* Body impedance analysis (BIA)~* US~* DXA
Study: NCT06645002

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: stevia rebaudiana bertoni
Description: effect of short term study (7 days) of stevia leave powder 1000 mg/day in diabetic subjects

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: stevia rebaudiana bertoni
Description: effect of short term study (7 days) of stevia leave powder 1000 mg/day in diabetic subjects

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: stevia rebaudiana bertoni
Description: effect of long term study (60 days) of stevia leave powder 1000 mg/day in diabetic subjects
Study: NCT05263596

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: dual x-ray absorptiometry, body impedance analysis, muscle strength measurements, ultrasound
Description: Results from the routine geriatric assessment:~* Mini Mental State Exam (MMSE)~* Clock-drawing test (CDT)~* Geriatric depression scale (GDS)~* Functional independence measure (FIM) at admission~* Timed up and go Test (TUG)~* Gait speed~* Hand grip strength (HGS)~* Nutritional risk screening (NRS)~Additional measurements:~* Chair-stand-test~* Clinical frailty scale (CFS)~* Calf circumference and mid-arm circumference~* Body impedance analysis (BIA)~* US~* DXA

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: dual x-ray absorptiometry, body impedance analysis, muscle strength measurements, ultrasound
Description: Results from the routine geriatric assessment:~* Mini Mental State Exam (MMSE)~* Clock-drawing test (CDT)~* Geriatric depression scale (GDS)~* Functional independence measure (FIM) at admission~* Timed up and go Test (TUG)~* Gait speed~* Hand grip strength (HGS)~* Nutritional risk screening (NRS)~Additional measurements:~* Chair-stand-test~* Clinical frailty scale (CFS)~* Calf circumference and mid-arm circumference~* Body impedance analysis (BIA)~* US~* DXA
Study: NCT04706910

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 18F-DOPA
Description: All participants will receive an intravenous injection of 18F-DOPA (4MBq/kg; minimum 110 MBq, maximum 600 MBq) for this study

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Furosemide Injection
Description: Some participants will receive an intravenous injection of furosemide (40mg, single dose)
Study: NCT06206265

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TRYP-0082
Description: Participants will receive one dose of 25 mg of oral psilocybin on the first dosing day and a second dose of 25mg oral psilocybin on the second dosing day. TRP 8802 will be administered in a comfortable setting under the guidance of the same two therapists from the preparation period. Participants will have an in-person study visit following the resolution of the psychoactive effects of the psilocybin (as determined by the therapists in discussion with the participant) to ensure participant's safety and comfort.

Intervention type: DRUG
Group type: OTHER
Intervention: TRYP-0082
Description: Participants will receive one dose of 25 mg of oral psilocybin on the first dosing day and a second dose of 25mg oral psilocybin on the second dosing day. TRP 8802 will be administered in a comfortable setting under the guidance of the same two therapists from the preparation period. Participants will have an in-person study visit following the resolution of the psychoactive effects of the psilocybin (as determined by the therapists in discussion with the participant) to ensure participant's safety and comfort.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychotherapy
Description: Participants will receive one dose of 25 mg of oral psilocybin on the first dosing day and a second dose of 25mg oral psilocybin on the second dosing day. TRP 8802 will be administered in a comfortable setting under the guidance of the same two therapists from the preparation period. Participants will have an in-person study visit following the resolution of the psychoactive effects of the psilocybin (as determined by the therapists in discussion with the participant) to ensure participant's safety and comfort.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Psychotherapy
Description: Participants will receive one dose of 25 mg of oral psilocybin on the first dosing day and a second dose of 25mg oral psilocybin on the second dosing day. TRP 8802 will be administered in a comfortable setting under the guidance of the same two therapists from the preparation period. Participants will have an in-person study visit following the resolution of the psychoactive effects of the psilocybin (as determined by the therapists in discussion with the participant) to ensure participant's safety and comfort.
Study: NCT06207838

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MiniMed 780G system
Description: The MiniMed™ 780G system automatically adjust insulin delivery to patient needs for an easier way to stabilise glucose levels. It features an advance level of automation for diabetes management, known as SmartGuard™ technology. If patient glucose levels are trending high, it gives patient more insulin. Technology is CE marked.
Study: NCT06202690

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Single-port robotic-assisted thoracic surgery
Description: All patients : 145 patients Single-port anatomical pulmonary resection(segmentectomy, lobectomy) with a complete mediastinal lymph node dissection will be performed using the SP robotic system.~A 4-cm single incision will be made below the subcostal margin. A chest tube will be inserted in same incision.

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Single-port video-assisted thoracoscopic surgery
Description: All patients : 145 patients Single-port anatomical pulmonary resection(segmentectomy, lobectomy) with a complete mediastinal lymph node dissection will be performed using the VATS.~A 4-cm single incision will be made at 5th intercostal space. A chest tube will be inserted in same incision.
Study: NCT05862597

Intervention type: DIAGNOSTIC_TEST
Intervention: HRV and Pulse diagnosis
Description: Palpation of the 6 pulse positions (right cun, right guan, right chi, left cun, left guan, left chi) measured by the pulse diagnostic instrument.

Intervention type: DIAGNOSTIC_TEST
Intervention: HRV and Pulse diagnosis
Description: Palpation of the 6 pulse positions (right cun, right guan, right chi, left cun, left guan, left chi) measured by the pulse diagnostic instrument.
Study: NCT06335134

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XW003 injection
Description: Administered subcutaneously

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XW003 injection
Description: Administered subcutaneously

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin
Description: Administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Warfarin
Description: Administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Description: Administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Digoxin
Description: Administered orally
Study: NCT06015971

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: omega-3
Description: Take 2 omega-3 enriched oral supplements per day plus physical activity and Mediterranean Diet

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Standard
Description: Take 2 hypercaloric hyperproteic oral supplements per day plus physical activity and Mediterranean Diet
Study: NCT04670575

Intervention type: PROCEDURE
Intervention: Cataract Surgery with Implantation of Vivity Extended Range of Vision IOL
Description: Patients with early stage glaucoma implanted with Vivity or Vivity Toric IOL
Study: NCT06487364

Intervention type: OTHER
Intervention: Rehabilitation
Description: A routine physical therapy program prescribed by a specialist physician and physiotherapist will be applied.
Study: NCT05797662

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propranolol
Description: Adults: Propanolol 120 mg tablets by mouth twice daily for up to 24 weeks Children: Propanolol 3 mg/kg suspension, divided dose twice daily for up to 24 weeks
Study: NCT04266223

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mask-free surface monitoring
Description: Mask-free headrest and couch for patient positioning for radiation therapy combined with a surface monitoring system
Study: NCT06477133

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate
Description: Pre-mixed solution of 2 grams of magnesium sulfate dissolved in 20 mL sterile water
Study: NCT05561855

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: lifestyle intervention
Description: During the 3-month lifestyle intervention period, the participants need to complete the weight monitoring, behavioral goal recording, diet and exercise recording, online course learning by using the WeChat official account module of Weight Loss and Glucose Control.They will receive corresponding feedback and integral rewards every week, and receive monthly follow-ups to complete health education, goal review, motivational interview as well as collecting medication changes and blood glucose monitoring data.
Study: NCT06691958

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Tortilla corn chips 4-5 pieces, eat one piece at time
Description: Snack
Study: NCT05062590

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Recommendations
Description: Ressources recommendations and interventions curated to the needs of the EP such as refering them to a social activity for socially isolated EP
Study: NCT06016556

Intervention type: DRUG
Intervention: nirmatrelvir, ritonavir
Description: single cohort
Study: NCT06691958

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tortilla corn chips 4-5 pieces, eat one piece at time
Description: Snack

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Tortilla corn chips 90 grams
Description: Snack

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tortilla corn chips 90 grams
Description: Snack

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Extruded corn chips 90 grams
Description: Snack

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Extruded corn chips 90 grams
Description: Snack

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Extruded corn chips 90 grams
Description: Snack

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Extruded corn chips 4-5 pieces, eat one piece at time
Description: Snack
Study: NCT05513690

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Amnioinfusion at room temperature (intervention arm)
Description: Routine amnioinfusion and intrauterine temperature probe sensor
Study: NCT05692258

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acupuncture
Description: Acupuncture is a kind of therapy used to treat diseases, in which a needle (usually a millimeter needle) is inserted into a patient's skin or tissue at a certain Angle to stimulate a specific part of the body (acupoint).~Disposable sterile acupuncture filiform needle (0.30mm×25mm、0.30mm×40mm), Guizhou Andi Medical Equipment Co, LTD, Guizhou Food and Drug Supervision and Equipment Production Xu 20170011.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Acupuncture
Description: Acupuncture is a kind of therapy used to treat diseases, in which a needle (usually a millimeter needle) is inserted into a patient's skin or tissue at a certain Angle to stimulate a specific part of the body (acupoint).~Disposable sterile acupuncture filiform needle (0.30mm×25mm、0.30mm×40mm), Guizhou Andi Medical Equipment Co, LTD, Guizhou Food and Drug Supervision and Equipment Production Xu 20170011.
Study: NCT05750095

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Incredible Years Autism Spectrum and Language Delay Programme
Description: Incredible Years Autism Spectrum and Language Delay Programme is a manualised group based intervention in 13 weekly 2-hour sessions. The programme targets parents of children aged 2-6 years, with autism spectrum disorder or language delay.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: First Aid for Parents
Description: First Aid for Parents is a program consisting of three full day work-shops targeting communication, interaction and daily living skills for parents of children with autism spectrum disorders
Study: NCT06691958

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Extruded corn chips 4-5 pieces, eat one piece at time
Description: Snack

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Extruded corn chips 4-5 pieces, eat one piece at time
Description: Snack